Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Dipanjan BanchurSince

3 Fintech Stocks to Add to Your Watchlist This Fall and 1 to Avoid

The fintech industry has grown significantly over the past few years due to the pandemic-driven accelerated pace of digitization. Continued digitization of businesses and financial transactions should keep driving the industry’s growth. Thus, investors could add promising fintech stocks Visa (V), AssetMark Financial (AMK), and Regional Management (RM) to their…

StockNews.com

There Is a Lot of Buzz About SoFi Stock. Is It a Buy?

There has been a lot of buzz around SoFi Technologies (SOFI) since President Biden announced the student loan relief program. However, the stock has declined more than 65% year-to-date. Given its weak earnings growth prospects, will it be wise to buy the stock now? Read on to learn our view….

StockNews.com

Should you Buy This Most Active Stock on Wall Street?

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

5 ETFs to Avoid in This Volatile Market

The Fed’s aggressive monetary policy stance is expected to keep the stock market under pressure in the upcoming months. Moreover, a potential recession could keep several assets under pressure. Therefore, we think it could be wise to avoid ETFs iShares 20+ Year Treasury Bond (TLT), VanEck Gold Miners (GDX), Ark…

StockNews.com

Sell This Cruise Ship Stock Before It Plunges Even Lower

Despite gaining more than 15% in price over the past three months, Norwegian Cruise Line Holdings (NCLH) is down close to 35% year-to-date. With the Fed reiterating its aggressive monetary policy stance, it could be wise to sell the stock before it plunges even lower. Read on….

StockNews.com

The Most Sought-After Tech Stock to Buy Right Now

Shares of Microsoft (MSFT) have shed more than 25% year-to-date, with the rising interest rates causing a massive tech sell-off. However, the current low price level allows long-term investors to take a position in the stock to benefit from its solid growth prospects. The company has guided double-digit growth for…

StockNews.com

1 Biotech Stock That Has Fallen Hard in 2022

Biotech stock Timber Pharmaceuticals (TMBR) is down more than 70% year-to-date. Analysts expect it to keep reporting losses over the next two years. So, will it be wise to buy the stock now? Read on to learn our view….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

5 Overhyped Stocks on Wall Street to Avoid Right Now

Wall Street has been abuzz with the return of the meme stocks craze over the past few months. However, as the stock market is expected to remain under considerable pressure in the upcoming months, it could be wise to avoid fundamentally weak overhyped stocks Rivian Automotive (RIVN), Coinbase (COIN), DraftKings…

StockNews.com

1 Stock Headed for a Chip-Wreck Right Now

Last few weeks have been difficult for NVIDIA (NVDA) as it reported a significant fall in its graphics segment revenue in the last quarter due to a slowdown in GPU sales. The company was later hit by an export ban by the U.S. government. After falling more than 55% year-to-date,…

StockNews.com

If You Own Either of These 2 Stocks, It's Time to Sell

The Fed’s aggressive interest rate hikes are expected to keep the stock market under pressure in the upcoming months. Amid this backdrop, investors still owning fundamentally weak stocks, Roblox (RBLX) and Marathon Digital (MARA), should sell them immediately to avoid losing further. Read more.

StockNews.com

3 Blockchain Stocks You Won't Find Any Gains In

Everyone is raving about blockchain technology due to its decentralized nature, wide application, and security. And companies working on this technology have thrived over the past several years. However, as macroeconomic concerns continue to affect the stock market, fundamentally weak blockchain stocks Block (SQ), Marathon Digital (MARA), and Riot Blockchain…

StockNews.com

Should You Buy This Biotech Stock Near Its 52-Week Low?

Recently listed biotech stock Comera Life Sciences is trading near its 52-week low. The stock is down more than 75% year-to-date. Although the $15 million purchase agreement with Arena Business Solutions is expected to help it invest in its product pipeline and formulation platform SQore, will it be wise to…

StockNews.com

1 Stock to Sell Before It Falls Even Lower

Television streaming platform fuboTV (FUBO) is trading more than 85% below its 52-week high. Despite the company’s positive guidance for the long term, analysts don’t expect the company to turn profitable anytime soon. So, we think it could be wise to sell the stock before it tumbles further. Read on….

StockNews.com

1 Volatile Stock to Avoid During the Next Market Swing

The stock and the crypto markets have been under pressure due to macroeconomic and geopolitical concerns. Crypto mining stock Riot Blockchain (RIOT) has fallen more than 65% year-to-date. With the crypto space expected to remain under pressure in the upcoming months, it could be wise to avoid the stock now.…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock You'll Wish You Bought Sooner

Amid the highly uncertain market conditions, investors must look for stocks with ample room for growth and better stability. Biopharmaceutical major Pfizer’s (PFE) products remain in demand irrespective of economic cycles. Given its robust financials, discounted valuation, and high profitability, it could be wise to invest in this defensive stock.…

StockNews.com

3 Heavily Shorted Stocks to Stay Away From This Fall

The major market indexes have been under pressure since the beginning of the year due to macroeconomic and geopolitical concerns. This has significantly benefitted short-sellers. However, since the market is expected to remain uncertain, it could be wise for investors looking to bottom fish to stay away from heavily shorted…

StockNews.com

The Worst Biotech Stock to Own in September

Biotech stock Ginkgo Bioworks (DNA) has fallen more than 60% year-to-date. The company has been making some acquisitions recently to aid its growth over the next few years. However, given its weak financials and unfavorable analyst estimates, it may not be wise to invest in this stock now. Continue reading….

StockNews.com

3 Stocks to Avoid as the Meme Craze Makes Its Comeback

The meme craze is back in action after a lull for a few months. Several stocks have gained traction of late despite their weak fundamentals. With the stock market expected to remain under pressure in the upcoming months, it could be wise to avoid fundamentally weak meme stocks Lucid (LCID),…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock to Avoid Despite It Being Less Than $5

After declining more than 70% year-to-date, fuboTV (FUBO) is currently trading below $5. Analysts expect its EPS to remain negative over the next two years. Given its weak financials and profitability, it could be wise to avoid the stock now. Read on….

StockNews.com

1 Stock You Should Consider Leaving Behind

Online brokerage Robinhood Markets (HOOD), which made commission-free trades popular, had a stellar run post its listing last year. However, the company soon ran out of steam as its growth slowed, and losses rose with a decline in users. Given its weak financials and unfavorable analyst estimates, it could be…

StockNews.com

Should You Buy, Sell or Hold CSX Stock at $32?

Shares of railroad operator CSX Corporation (CSX) are trading above their 50-day and 100-day moving averages, indicating an uptrend. Despite the uncertain macroeconomic environment, analysts expect the company’s revenue and earnings to rise this year. So, let’s evaluate if it’s worth adding the stock to one’s portfolio now….

StockNews.com

1 Financial Stock in the Buy Zone Right Now

Payment technology major Visa (V) reported substantial revenue and earnings growth in the last quarter despite geopolitical and macroeconomic headwinds impacting most sectors. Analysts expect it to continue reporting strong revenue and EPS growth. So, we think it could be wise to buy the stock now. Read on….

StockNews.com

1 ETF Most Investors Still Find Attractive Right Now

Despite gaining more than 40% year-to-date, Energy Select Sector SPDR Fund (XLE) still looks attractive to investors due to the expected rise in energy prices by the end of this year. Therefore, it could be wise to buy this ETF now. Read on….

StockNews.com

PLTR Is a Falling Knife, Not a Buy the Dip Opportunity

Shares of Palantir Technologies (PLTR) are currently trading more than 70% below their 52-week high. With the company lowering its guidance for the current year, will it be wise to buy the dip in the stock now? Read on to learn our view….

StockNews.com

1 Leveraged Equity ETF to Avoid and 2 to Buy

Leveraged equity ETFs are usually rewarding investments when the short-term prospects of their underlying industry or instruments are apparent. Given the resilience of the utility sector amid the current market volatility, ProShares Ultra Utilities (UPW) could be a good investment. Also, MicroSectors Gold Miners -3X Inverse Leveraged ETNs (GDXD) should…

1 … 20 21 22 23

People

Joe Biden

67,081 stories

Dipanjan BanchurSince

722 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.